Leadership, Planning and Evaluation

领导、规划和评估

• 批准号: 9789591
• 负责人: Stephen D. Nimer
• 金额: $ 15.24万
• 依托单位: UNIVERSITY OF MIAMI SCHOOL OF MEDICINE
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-07-10 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/9789591
• 关键词: Adherence; Advisory Committees; Basic Science; Cancer Center Support Grant; Catchment Area; Clinical; Clinical Research; Clinical Sciences; Community Outreach; Comprehensive Cancer Center; Counseling; Decision Making; Environment; Evaluation; Feedback; Funding; Funding Opportunities; Goals; Growth; Leadership; Mission; Physicians; Population Sciences; Quality of Care; Recommendation; Research; Resource Sharing; Review Committee; Services; Strategic Planning; TimeLine; Training Activity; Training and Education; Translational Research; Universities; Vision; anticancer research; cancer education; experience; high standard; member; oncology service; population based; programs; success; Adherence; Advisory Committees; Basic Science; Cancer Center Support Grant; Catchment Area; Clinical; Clinical Research; Clinical Sciences; Community Outreach; Comprehensive Cancer Center; Counseling; Decision Making; Environment; Evaluation; Feedback; Funding; Funding Opportunities; Goals; Growth; Leadership; Mission; Physicians; Population Sciences; Quality of Care; Recommendation; Research; Resource Sharing; Review Committee; Services; Strategic Planning; TimeLine; Training Activity; Training and Education; Translational Research; Universities; Vision; anticancer research; cancer education; experience; high standard; member; oncology service; population based; programs; success

PROJECT SUMMARY: LEADERSHIP, PLANNING, AND EVALUATION Stephen D. Nimer, MD, was appointed as Sylvester Comprehensive Cancer Center (Sylvester) Director in 2012. Under his leadership, Sylvester has experienced exponential growth, driven by its dedicated leadership team, its highly engaged and experienced External Advisory Board (EAB), its productive relationship with University leadership, and its adherence to a carefully constructed 2014-2018 Strategic Plan with clear standards, timelines, goals, and deliverables. Nimer leads Sylvester with the assistance of a senior leadership team comprised of a Deputy Director, six Associate Directors, an Associate Vice President, and Physician-in-Chief for the Oncology Service Line. Collectively, this team provides thoughtful and important counsel to the Director, including strategies that promote the growth of Sylvester’s basic, translational, clinical, and population science research portfolio; education and training activities; community outreach and engagement capabilities; shared resource support; and its ability to define new research directions and create new programs and funding opportunities for its members. In addition to the guidance offered by Sylvester’s robust senior leadership team, Sylvester has seven internal review committees that provide recommendations and oversee the implementation of Sylvester’s activities and strategic plans; including the Executive Committee, Space Allocation, Intramural Funding Program (IFP), Scientific Steering Committee (SSC), Clinical Research Internal Advisory Board (CRIAB), Cancer Education Leadership Council (CELC), and Community Outreach and Engagement Internal Advisory Board (COE IAB). Additionally, two external advisory entities—the External Advisory Board (EAB) and the Board of Overseers (BOO)—provide advice and expertise that is critical to Sylvester’s success. Supplementing Sylvester’s senior leadership and internal and external advisory committees are the many planning and evaluation efforts (e.g. Shared Resource Advisory Groups (SR AG) and Membership), which are presented for consideration and action to the Scientific Steering and Executive Committees. In aggregate, feedback from these advisory entities allows Sylvester to obtain effective internal and external advice, set priorities, make decisions, and define and evaluate the Center’s strategic plans and activities. These activities drive Sylvester’s mission and vision maximizing the Center’s ability to advance a full cancer research agenda, maintain the highest standard/quality of care and research, and serve its unique catchment area, one with unparalleled diversity.

项目摘要：领导，计划和评估 医学博士Stephen D. Nimer于2012年被任命为西尔维斯特综合癌症中心（Sylvester）主任。 在他的领导下，西尔维斯特（Sylvester）经历了指数级的增长，这是由敬业的领导团队驱动的 它高度参与和经验丰富的外部顾问委员会（EAB），与大学的富有成效关系 领导层及其坚持一项精心构建的2014 - 2018年战略计划，具有明确的标准， 时间表，目标和可交付成果。 Nimer在高级领导团队的协助下领导西尔维斯特 完成副董事，六位副董事，副副总裁和总理 对于肿瘤服务线。该团队共同为董事提供了周到且重要的律师 包括促进西尔维斯特基本，翻译，临床和人口科学的增长的策略 研究组合；教育和培训活动；社区宣传和参与能力；共享 资源支持；及其定义新的研究方向并创建新计划和资金的能力 其成员的机会。除了西尔维斯特强大的高级领导团队提供的指导外 西尔维斯特（Sylvester）有七个内部审查委员会，他们提供建议并监督 实施西尔维斯特的活动和战略计划；包括执行委员会，太空 分配，壁内资金计划（IFP），科学指导委员会（SSC），临床研究内部 顾问委员会（CRIAB），癌症教育领导委员会（CELC）和社区外展和 参与内部顾问委员会（COE IAB）。此外，两个外部咨询实体 - 外部 顾问委员会（EAB）和监督委员会（BOO） - 提供的建议和专业知识至关重要 西尔维斯特的成功。补充西尔维斯特的高级领导以及内部和外部咨询 委员会是许多计划和评估工作（例如共享资源咨询小组（SR AG） 和会员资格），将其提交给科学转向和执行 委员会。总体而言，来自这些咨询实体的反馈允许Sylvester获得有效的内部 以及外部建议，设定优先级，做出决定，定义和评估中心的战略计划以及 活动。这些活动推动了西尔维斯特的使命和视野，最大程度地提高了中心的能力 癌症研究议程，保持最高标准/护理质量和研究，并为其独特 集水区，一个无与伦比的多样性。